The market shows low confidence in the effectiveness of the Russian cancer vaccine.
Current market probabilities indicate a strong skepticism regarding the Russian cancer vaccine's efficacy, with 84.18% betting against its success. The Pulse AI suggests a slightly higher probability for success at 20.82%, but overall confidence remains low at 45 out of 100. The market appears fairly priced, indicating balanced views among participants.